Feature | Responders (78) | Refractory (79) | P value |
---|---|---|---|
Age (years) | |||
> 50 (81) | 40 (51.3%) | 41 (51.9%) | 1.0 |
≤ 50 (76) | 38 (48.7%) | 38 (48.1%) | |
Menstrual status | |||
Pre (73) | 36 (46.2%) | 37 (46.8%) | 1.0 |
Post (84) | 42 (53.8%) | 42 (53.2%) | |
Histological grade | |||
II (114) | 57 (73.1%) | 57 (72.2%) | 0.69 |
III (43) | 21 (26.9) | 22 (27.8%) | |
Contraception | |||
Yes (31) | 17 (21.8%) | 14 (17.7%) | 0.55 |
No (126) | 61 (78.2%) | 65 (82.3%) | |
Her-2 status | |||
+ve (58) | 31 (39.7%) | 27 (34.2%) | 0.51 |
−ve (99) | 47 (60.3%) | 52 (65.8%) | |
ER | |||
+ve (108) | 52 (66.7%) | 56 (70.9%) | 0.61 |
−ve (49) | 26 (33.3%) | 23 (29.1%) | |
PR | |||
+ve (78) | 38 (48.7%) | 40 (50.6%) | 1.00 |
−ve (79) | 40 (51.3%) | 39 (49.4%) | |
Disease site | |||
Bone only (46) | 31 (39.7%) | 15 (18.9%) | 0.005* |
Visceral (111) | 47 (60.3%) | 64 (81.1%) |